See more : Auren Energia S.A. (AURE3.SA) Income Statement Analysis – Financial Results
Complete financial analysis of HealthEquity, Inc. (HQY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HealthEquity, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Quest Co., Ltd. (2332.T) Income Statement Analysis – Financial Results
- Uniphos Enterprises Limited (UNIENTER.NS) Income Statement Analysis – Financial Results
- Atlanticus Holdings Corporation 9.25% Senior Notes due 2029 (ATLCZ) Income Statement Analysis – Financial Results
- Huasu Holdings Co.,Ltd (000509.SZ) Income Statement Analysis – Financial Results
- LOTTE Fine Chemical Co., Ltd. (004000.KS) Income Statement Analysis – Financial Results
HealthEquity, Inc. (HQY)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.healthequity.com
About HealthEquity, Inc.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 999.59M | 861.75M | 756.56M | 733.57M | 531.99M | 287.24M | 229.53M | 178.37M | 126.79M | 87.86M | 62.02M | 46.09M |
Cost of Revenue | 376.95M | 371.66M | 332.85M | 318.24M | 206.08M | 106.05M | 94.61M | 72.02M | 54.19M | 39.88M | 29.21M | 21.97M |
Gross Profit | 622.64M | 490.09M | 423.71M | 415.33M | 325.91M | 181.19M | 134.92M | 106.36M | 72.60M | 47.97M | 32.80M | 24.12M |
Gross Profit Ratio | 62.29% | 56.87% | 56.00% | 56.62% | 61.26% | 63.08% | 58.78% | 59.63% | 57.26% | 54.60% | 52.89% | 52.33% |
Research & Development | 218.81M | 193.38M | 157.36M | 124.81M | 77.58M | 35.06M | 27.39M | 22.38M | 16.83M | 10.50M | 7.14M | 4.23M |
General & Administrative | 103.66M | 95.63M | 84.38M | 84.49M | 60.56M | 33.04M | 25.11M | 20.15M | 14.11M | 8.34M | 3.90M | 3.37M |
Selling & Marketing | 79.27M | 68.85M | 58.61M | 49.96M | 43.95M | 29.50M | 23.14M | 18.32M | 13.30M | 10.62M | 8.60M | 7.80M |
SG&A | 182.93M | 164.48M | 142.98M | 134.46M | 104.51M | 62.54M | 48.25M | 38.47M | 27.42M | 18.96M | 12.50M | 11.16M |
Other Expenses | 0.00 | 94.59M | 82.79M | 76.06M | 34.70M | -1.85M | -2.23M | -1.09M | -589.00K | -374.00K | -129.00K | -147.00K |
Operating Expenses | 401.74M | 452.44M | 383.14M | 335.33M | 216.79M | 103.52M | 80.50M | 65.14M | 46.46M | 31.10M | 21.28M | 17.03M |
Cost & Expenses | 871.45M | 824.10M | 715.99M | 653.57M | 422.88M | 209.57M | 175.11M | 137.16M | 100.64M | 70.98M | 50.49M | 39.00M |
Interest Income | 12.14M | 1.76M | 1.50M | 1.05M | 5.91M | 1.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 55.46M | 48.42M | 36.57M | 34.88M | 24.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.00K | 326.00K |
Depreciation & Amortization | 153.08M | 161.20M | 137.19M | 115.90M | 55.35M | 18.19M | 15.95M | 13.19M | 8.60M | 1.64M | 4.27M | 3.37M |
EBITDA | 282.42M | 171.53M | 102.97M | 154.93M | 123.28M | 94.00M | 68.14M | 54.40M | 34.74M | 22.76M | 15.79M | 10.19M |
EBITDA Ratio | 28.25% | 23.22% | 22.71% | 27.15% | 29.21% | 33.37% | 30.66% | 30.50% | 27.40% | 20.64% | 25.26% | 22.37% |
Operating Income | 128.13M | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M | 54.42M | 41.21M | 26.14M | 16.87M | 11.52M | 7.09M |
Operating Income Ratio | 12.82% | 4.52% | 4.58% | 11.35% | 14.48% | 27.04% | 23.71% | 23.10% | 20.62% | 19.21% | 18.58% | 15.39% |
Total Other Income/Expenses | -53.09M | -47.15M | -42.50M | -29.87M | -33.85M | -1.85M | -2.23M | -1.09M | -589.00K | -1.11M | -6.15M | -590.00K |
Income Before Tax | 75.04M | -38.10M | -66.74M | 4.14M | 43.16M | 75.82M | 52.19M | 40.12M | 25.55M | 15.76M | 5.37M | 6.50M |
Income Before Tax Ratio | 7.51% | -4.42% | -8.82% | 0.56% | 8.11% | 26.40% | 22.74% | 22.49% | 20.16% | 17.94% | 8.67% | 14.11% |
Income Tax Expense | 19.33M | -11.95M | -22.45M | -4.69M | 3.49M | 1.92M | 4.83M | 13.74M | 8.94M | 5.60M | 4.14M | -4.67M |
Net Income | 55.71M | -26.14M | -44.29M | 8.83M | 39.66M | 73.90M | 47.36M | 26.38M | 16.61M | 10.17M | 1.23M | 11.17M |
Net Income Ratio | 5.57% | -3.03% | -5.85% | 1.20% | 7.46% | 25.73% | 20.63% | 14.79% | 13.10% | 11.57% | 1.99% | 24.23% |
EPS | 0.65 | -0.31 | -0.53 | 0.12 | 0.59 | 1.20 | 0.79 | 0.45 | 0.29 | 0.39 | -1.26 | 0.51 |
EPS Diluted | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 | 1.17 | 0.77 | 0.44 | 0.28 | 0.21 | -1.26 | 0.21 |
Weighted Avg Shares Out | 85.56M | 84.44M | 83.13M | 74.24M | 67.03M | 61.84M | 60.30M | 58.62M | 56.72M | 31.18M | 5.65M | 7.76M |
Weighted Avg Shares Out (Dil) | 86.96M | 84.44M | 83.13M | 75.68M | 68.45M | 63.37M | 61.85M | 59.89M | 58.86M | 51.86M | 5.65M | 45.85M |
Unlocking Q3 Potential of HealthEquity (HQY): Exploring Wall Street Estimates for Key Metrics
HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators
HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue?
Investment Committee Moves: EPAM, Paycom, Blackstone, Healthequity, Booz Allen, Leidos, and Vertiv
HealthEquity Gains 54.6% YTD: What's Driving the Stock?
HealthEquity: High Marks For Recent Profit Growth
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards
Strength Seen in HealthEquity (HQY): Can Its 3.5% Jump Turn into More Strength?
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now
Source: https://incomestatements.info
Category: Stock Reports